Advertisement

Journal of Neurology

, Volume 253, Issue 8, pp 1060–1063 | Cite as

Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging

  • Sanjay KalraEmail author
  • Peter Tai
  • Angela Genge
  • Douglas L. Arnold
Article

Abstract

Riluzole prolongs survival in amyotrophic lateral sclerosis. The temporal and spatial profile of its effect on the brain is unknown. We used proton magnetic resonance spectroscopic imaging to evaluate the neuronal response to 1 day of riluzole treatment in motor and non-motor regions of the brain. In 10 patients the N-acetylaspartate/total creatine (NAA/Cr) ratio increased in the precentral gyrus and supplementary motor area, but not in the post-central gyrus or parietal lobe. Improvement in cortical neuronal metabolic function in the motor cortex occurs early with riluzole treatment.

Keywords

amyotrophic lateral sclerosis magnetic resonance spectroscopy n-acetylaspartate 

Notes

Acknowledgement

We thank the patients for their voluntary participation. This study was supported in part by the ALS Association of America and by Aventis Pharmaceuticals.

References

  1. 1.
    Cendes F, Andermann F, Dubeau F, Matthews PM, Arnold DL (1997) Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology 49:1525–1533PubMedGoogle Scholar
  2. 2.
    Dautry C, Vaufrey F, Brouillet E, Bizat N, Henry PG, Conde F, Bloch G, Hantraye P (2000) Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3- nitropropionic acid. J Cereb Blood Flow Metab 20:789–799PubMedCrossRefGoogle Scholar
  3. 3.
    De Stefano N, Matthews PM, Arnold DL (1995) Reversible decreases in N-acetylaspartate after acute brain injury. MRM (AUTHOR PLEASE GIVE INDEX MEDICUS NAME OF JOURNAL)34:721–727Google Scholar
  4. 4.
    Ernst T (2005) Quantification and analysis in MR spectroscopy In: Gillard JH, Waldman AD, Barker PB (eds) Clinical MR Neuroimaging. Diffusion, Perfusion and Spectroscopy Cambridge University Press Cambridge pp. 27–37Google Scholar
  5. 5.
    Kalra S, Cashman NR, Genge A, Arnold DL (1998) Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 9:1757–1761PubMedGoogle Scholar
  6. 6.
    Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 347:1425–1431PubMedGoogle Scholar
  7. 7.
    Martin JE, Swash M (1995) The pathology of motor neuron disease In: Leigh PN, Swash M (eds) Motor Neuron Disease. Biology and Management Springer-Verlag London pp. 93–118Google Scholar
  8. 8.
    Moreno A, Ross BD, Bluml S (2001) Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by (13)C MRS and [1-(13)C]glucose infusion. J Neurochem 77:347–350PubMedCrossRefGoogle Scholar
  9. 9.
    Parent A (1996) Carpenter’s Human Neuroanatomy Williams and Wilkins BaltimoreGoogle Scholar
  10. 10.
    Pioro EP, Antel JP, Cashman NR, Arnold DL (1994) Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 44:1933–1938PubMedGoogle Scholar
  11. 11.
    Schinder AF, Olson EC, Spitzer NC, Montal M (1996) Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. Journal of Neuroscience 16:6125–6133PubMedGoogle Scholar
  12. 12.
    Stefan K, Kunesch E, Benecke R, Classen J (2001) Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis. Ann Neurol 49:536–539PubMedCrossRefGoogle Scholar
  13. 13.
    Vion-Dury J, Nicoli F, Salvan AM, Confort-Gouny S, Dhiver C, Cozzone PJ (1995) Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet 345:60–61PubMedCrossRefGoogle Scholar
  14. 14.
    Zhu XH, Chen W (2001) Observed BOLD effects on cerebral metabolite resonances in human visual cortex during visual stimulation: a functional (1)H MRS study at 4 T Magn Reson. Med 46:841–847PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff Verlag Darmstadt 2006

Authors and Affiliations

  • Sanjay Kalra
    • 1
    Email author
  • Peter Tai
    • 1
  • Angela Genge
    • 2
  • Douglas L. Arnold
    • 2
  1. 1.Division of Neurology, Department of MedicineUniversity of AlbertaEdmontonCanada
  2. 2.Montreal Neurological Institute and HospitalMcGill UniversityMontrealCanada

Personalised recommendations